PAX8 and neoplasm: PAX8 transactivates the promoters of the telomerase catalytic subunit (hTERT) and the telomerase RNA component (hTR) to increase telomerase activity [17], and as might be predicted, the majority of the telomerase-positive tumours were also PAX8-positive.